Aldeyra Therapeutics (ALDX) Q3 2026 Earnings

31JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.24
-0.18
-0.12
-0.06

Details

Expected EPS
-0.0775
Actual EPS
N/A
Surprise EPS
0.08
Surprise Percent
+100%

Description

Aldeyra Therapeutics (ALDX) will report earnings of for Q3 2026 on July 31, 2026.

0 Comments

Share your thoughts